Fig. 4
From: French recommendations for the management of systemic sclerosis
Management of scleroderma renal crisis. BP blood pressure, PO per os, RAS renin–angiotensin system, ACE conversion enzyme inhibitors, ARB II angiotensin receptor blockers II, MAP mean arterial pressure, IV intravenous, CT computerized tomography, MRI magnetic resonance imaging, CI contraindication, IV intravenous, HBP high blood pressure, AKI acute kidney injury, PE plasma exchange, LDH lactate dehydrogenase